Medical University of South Carolina (MUSC)
Multiple Industry Partners
The SmartState Center in Tobacco-Related Malignancy is devoted to discovering biomarkers of tobacco-related malignancies. The initial focus is on lung cancer, but Center leaders hope to make advances in other tobacco-related malignancies, including head and neck, bladder, and esophageal cancers. The Center’s goals include:
In conjunction with the Hollings Cancer Center, the Center partners with the U.S. Department of Veteran Affairs, the South Carolina Department of Health and Environmental Control, the South Carolina Cancer Alliance, and other state hospital systems. These same partners, along with Health Sciences South Carolina and the Medical University Hospital Authority, will work with the Center to develop a distributed tissue repository and a clinical trials network.
In 2008, the Center, in conjunction with the Hollings Cancer Center, formed an alliance with the University of Colorado Comprehensive Cancer Center on a renewal of an National Cancer Institute-funded Specialized Center of Research Excellence in Lung Cancer.
Two faculty members associated with the Center, Drs. Robert Gemmill and Harry Drabkin, have clinical trials partnerships with Syndax, Pfizer, and Novartis for more than $1.25 million in funding.
As a result of the National Cancer Institute (NCI) designation for the Hollings Cancer Center, a new collaborative project, NAVIGATE, has been initiated with Spartanburg Regional Healthcare System and St. Joseph’s/Candler Hospital in Savannah to define specific barriers experienced by thoracic and esophageal cancer patients when seeking timely treatment options.
Since inception, the Center has received more than $12 million in research funding. The Center also participated in the application of the NCI Cancer Center Designation award and the $20 million National Institutes of Health Clinical and Translational Science Award.
Extramural Funding Above Matching Requirement: $37.7 million